Startup profile for AxoNeural Therapeutics: what they do, why they are interesting, stage (seed), industries, and links to our funding articles. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker Logo
Venture Capital Tracker

Startup profile · funding coverage

AxoNeural Therapeutics startup funding profile

Cleveland Clinic spinout developing nanoparticle-delivered therapeutics for neurodegenerative injury.

Stage

seed

Status

private

Coverage

stub

Overview

AxoNeural Therapeutics was founded as a Cleveland Clinic spin-off to develop nanoparticle-delivered therapeutics for neurodegenerative injuries and diseases. Lead concept Neupron targets neuroprotection in acute spinal cord injury. Company materials and SBIR listings associate Cleveland addresses including Cedar Avenue / Clinic campus.

Why AxoNeural Therapeutics is interesting

Clinic nanomedicine translation — Neupron antioxidant enzyme delivery for acute spinal cord injury; Cleveland HQ.

Key facts

  • Cleveland Clinic spin-off (founded ~2020)
  • Lead: Neupron nanoparticle antioxidant therapy
  • Focus: spinal cord injury / neurodegenerative injury
  • HQ Cleveland, OH

Industries

Biotech & Life Sciences Healthtech

FAQs about AxoNeural Therapeutics

Practical answers founders, operators, and investors typically search for.

Develops nanoparticle-delivered therapeutics (Neupron) for neurodegenerative injuries such as spinal cord injury.
Cleveland Clinic spinout developing nanoparticle-delivered therapeutics for neurodegenerative injury.
Cleveland, OH
No — private as of July 2026.
seed
See investors / fundraisingRounds when disclosed; otherwise company press page.
biotech-life-sciences, healthtech
2020
https://axoneuraltherapeutics.com/
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.